CHRISTAL CARR: Open Payments
NPI 1568235133 · ALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,187 in 64 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $334 · 2025 $1,187
Food & beverage: $1,187
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $334 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $197 |
| Vanda Pharmaceuticals Inc. | 9 | $173 |
| Supernus Pharmaceuticals, Inc. | 6 | $114 |
| Otsuka America Pharmaceutical, Inc. | 6 | $105 |
| Janssen Pharmaceuticals, Inc | 3 | $74 |
| Axsome Therapeutics, Inc. | 4 | $67 |
| Lundbeck LLC | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 1 | $32 |
| Almatica Pharma LLC | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, FANAPT, REXULTI, Qelbree, Auvelity, SPRAVATO, COBENFY.
Industry payments across TX — which companies pay providers there.
